Relestat Ophthalmic Solution 0.05%

olopatadine hydrochloride · Allergan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Relestat Ophthalmic Solution 0.05%, covering 2014-04-29 to 2014-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea